Takeda Pharmaceutical expands portfolio of rare disease therapies in India

Takeda Pharmaceutical expands portfolio of rare disease therapies in India Under lysosomal storage disorders, India has been recording the prevalence of Hunter syndrome, Gaucher disease and Fabry disease.

No comments:

Post a Comment